AFP and neoplasm: A recent review identified several predictors of HCC recurrence, which include: patient related factors (underlying disease and hepatitis C virus treatment), the tumor related factors (tumor staging, vascular invasion, and differentiation grade), biomarkers (alpha-fetoprotein and the neutrophil lymphocyte ratio), radiological factors and treatment related factors (time on the waiting list, pre-transplant bridging therapy, and response to locoregional treatment (LRT)) [4,8].